Technical Analysis for SYBX - Synlogic, Inc.

Grade Last Price % Change Price Change
grade F 7.61 -3.43% -0.27
SYBX closed down 3.43 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SYBX trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 20 Oversold Stochastic Weakness -4.04%
Mar 19 180 Bearish Setup Bearish Swing Setup 0.13%
Mar 19 Oversold Stochastic Weakness 0.13%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.88%
Mar 18 Oversold Stochastic Weakness -4.88%
Mar 15 Stochastic Buy Signal Bullish -2.81%
Mar 15 Outside Day Range Expansion -2.81%
Mar 15 Oversold Stochastic Weakness -2.81%

Older signals for SYBX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
Cancer Biology Disease Diabetes Obesity Inflammatory Bowel Disease Inborn Errors Of Metabolism Synthetic Biology Phenylketonuria Intellectual Disability Newborn Screening Pku Rare Genetic Diseases
Is SYBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.59
52 Week Low 5.75
Average Volume 69,320
200-Day Moving Average 9.2669
50-Day Moving Average 8.2418
20-Day Moving Average 8.1965
10-Day Moving Average 7.85
Average True Range 0.5744
ADX 18.88
+DI 14.7552
-DI 21.8268
Chandelier Exit (Long, 3 ATRs ) 8.3168
Chandelier Exit (Short, 3 ATRs ) 9.1732
Upper Bollinger Band 9.1167
Lower Bollinger Band 7.2763
Percent B (%b) 0.18
BandWidth 22.453486
MACD Line -0.2244
MACD Signal Line -0.1586
MACD Histogram -0.0657
Fundamentals Value
Market Cap 123.91 Million
Num Shares 16.3 Million
EPS -9.33
Price-to-Earnings (P/E) Ratio -0.82
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.66
Resistance 3 (R3) 8.72 8.44 8.49
Resistance 2 (R2) 8.44 8.17 8.41 8.43
Resistance 1 (R1) 8.02 8.00 7.88 7.96 8.37
Pivot Point 7.74 7.74 7.67 7.71 7.74
Support 1 (S1) 7.32 7.47 7.18 7.26 6.85
Support 2 (S2) 7.04 7.30 7.01 6.79
Support 3 (S3) 6.62 7.04 6.74
Support 4 (S4) 6.56